CHIEF EXECUTIVE OFFICER S STATEMENT I am pleased to report the Group s interim results for the six-month period ended 31 October 2023. During the period, Scancell.
Scancell Holding: Catalysts are coming into view, says investment bank proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Key highlights for biotech group Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)’s financial year ending 30 April 2023 included a positive data reading arising.
Scancell focuses on development of two critical cancer fighting assets proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), which is developing groundbreaking immunotherapies, is set to showcase early promising results from its ModiFY.